chr10-101019138-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001195263.2(PDZD7):​c.1008C>T​(p.Pro336Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00823 in 1,545,728 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P336P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0070 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 57 hom. )

Consequence

PDZD7
NM_001195263.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.24

Publications

3 publications found
Variant links:
Genes affected
PDZD7 (HGNC:26257): (PDZ domain containing 7) This gene encodes a ciliary protein homologous to proteins which are mutated in Usher syndrome patients, and mutations and translocations involving this gene have been associated with two types of Usher syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
PDZD7 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive 57
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Usher syndrome type 2C
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 10-101019138-G-A is Benign according to our data. Variant chr10-101019138-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 178525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00696 (1061/152388) while in subpopulation NFE AF = 0.00961 (654/68036). AF 95% confidence interval is 0.009. There are 4 homozygotes in GnomAd4. There are 534 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDZD7NM_001195263.2 linkc.1008C>T p.Pro336Pro synonymous_variant Exon 8 of 17 ENST00000619208.6 NP_001182192.1 Q9H5P4-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDZD7ENST00000619208.6 linkc.1008C>T p.Pro336Pro synonymous_variant Exon 8 of 17 5 NM_001195263.2 ENSP00000480489.1 Q9H5P4-3

Frequencies

GnomAD3 genomes
AF:
0.00697
AC:
1061
AN:
152270
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00195
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00837
Gnomad ASJ
AF:
0.00864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0123
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00961
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00629
AC:
926
AN:
147152
AF XY:
0.00629
show subpopulations
Gnomad AFR exome
AF:
0.00128
Gnomad AMR exome
AF:
0.00495
Gnomad ASJ exome
AF:
0.00651
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00867
Gnomad NFE exome
AF:
0.00992
Gnomad OTH exome
AF:
0.00769
GnomAD4 exome
AF:
0.00837
AC:
11658
AN:
1393340
Hom.:
57
Cov.:
33
AF XY:
0.00821
AC XY:
5654
AN XY:
688628
show subpopulations
African (AFR)
AF:
0.00130
AC:
42
AN:
32282
American (AMR)
AF:
0.00497
AC:
183
AN:
36804
Ashkenazi Jewish (ASJ)
AF:
0.00727
AC:
183
AN:
25186
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36712
South Asian (SAS)
AF:
0.00267
AC:
213
AN:
79888
European-Finnish (FIN)
AF:
0.00752
AC:
263
AN:
34954
Middle Eastern (MID)
AF:
0.00504
AC:
27
AN:
5358
European-Non Finnish (NFE)
AF:
0.00956
AC:
10358
AN:
1083954
Other (OTH)
AF:
0.00668
AC:
389
AN:
58202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
868
1736
2605
3473
4341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00696
AC:
1061
AN:
152388
Hom.:
4
Cov.:
32
AF XY:
0.00717
AC XY:
534
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41602
American (AMR)
AF:
0.00836
AC:
128
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00864
AC:
30
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4834
European-Finnish (FIN)
AF:
0.0123
AC:
131
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00961
AC:
654
AN:
68036
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
54
108
163
217
271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00470
Hom.:
0
Bravo
AF:
0.00628
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Dec 18, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PDZD7: BP4, BP7, BS2 -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro336Pro in Exon 08 of PDZD7: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 0.5% (35/6694) of Eur opean American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs144469613). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
14
DANN
Benign
0.97
PhyloP100
1.2
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144469613; hg19: chr10-102778895; API